Chapter 1. Research Scope
1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
1.4.1. Market size breakdown, by product
1.4.2. Market size breakdown, by indication
1.4.3. Market size breakdown, by end user
1.4.4. Market size breakdown, by region
1.4.5. Market size breakdown, by country
1.5. Market Data Reporting Unit
1.5.1. Value
1.6. Key Stakeholders
Chapter 2. Research Methodology
2.1. Secondary Research
2.1.1. Paid
2.1.2. Unpaid
2.1.3. P&S Intelligence database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Voice of Industry Experts/KOLs
Chapter 5. Market Indicators
Chapter 6. Industry Outlook
6.1. Market Dynamics
6.1.1. Trends
6.1.2. Drivers
6.1.3. Restraints/challenges
6.1.4. Impact analysis of drivers/restraints
6.2. Impact of COVID-19
6.3. Porter’s Five Forces Analysis
6.3.1. Bargaining power of buyers
6.3.2. Bargaining power of suppliers
6.3.3. Threat of new entrants
6.3.4. Intensity of rivalry
6.3.5. Threat of substitutes
Chapter 7. Global Market
7.1. Overview
7.2. Market Revenue, by Product (2017–2030)
7.3. Market Revenue, by Indication (2017–2030)
7.4. Market Revenue, by End User (2017–2030)
7.5. Market Revenue, by Region (2017–2030)
Chapter 8. North America Market
8.1. Overview
8.2. Market Revenue, by Product (2017–2030)
8.3. Market Revenue, by Indication (2017–2030)
8.4. Market Revenue, by End User (2017–2030)
8.5. Market Revenue, by Country (2017–2030)
Chapter 9. Europe Market
9.1. Overview
9.2. Market Revenue, by Product (2017–2030)
9.3. Market Revenue, by Indication (2017–2030)
9.4. Market Revenue, by End User (2017–2030)
9.5. Market Revenue, by Country (2017–2030)
Chapter 10. APAC Market
10.1. Overview
10.2. Market Revenue, by Product (2017–2030)
10.3. Market Revenue, by Indication (2017–2030)
10.4. Market Revenue, by End User (2017–2030)
10.5. Market Revenue, by Country (2017–2030)
Chapter 11. LATAM Market
11.1. Overview
11.2. Market Revenue, by Product (2017–2030)
11.3. Market Revenue, by Indication (2017–2030)
11.4. Market Revenue, by End User (2017–2030)
11.5. Market Revenue, by Country (2017–2030)
Chapter 12. MEA Market
12.1. Overview
12.2. Market Revenue, by Product (2017–2030)
12.3. Market Revenue, by Indication (2017–2030)
12.4. Market Revenue, by End User (2017–2030)
12.5. Market Revenue, by Country (2017–2030)
Chapter 13. U.S. Market
13.1. Overview
13.2. Market Revenue, by Product (2017–2030)
13.3. Market Revenue, by Indication (2017–2030)
13.4. Market Revenue, by End User (2017–2030)
Chapter 14. Canada Market
14.1. Overview
14.2. Market Revenue, by Product (2017–2030)
14.3. Market Revenue, by Indication (2017–2030)
14.4. Market Revenue, by End User (2017–2030)
Chapter 15. Germany Market
15.1. Overview
15.2. Market Revenue, by Product (2017–2030)
15.3. Market Revenue, by Indication (2017–2030)
15.4. Market Revenue, by End User (2017–2030)
Chapter 16. France Market
16.1. Overview
16.2. Market Revenue, by Product (2017–2030)
16.3. Market Revenue, by Indication (2017–2030)
16.4. Market Revenue, by End User (2017–2030)
Chapter 17. U.K. Market
17.1. Overview
17.2. Market Revenue, by Product (2017–2030)
17.3. Market Revenue, by Indication (2017–2030)
17.4. Market Revenue, by End User (2017–2030)
Chapter 18. Italy Market
18.1. Overview
18.2. Market Revenue, by Product (2017–2030)
18.3. Market Revenue, by Indication (2017–2030)
18.4. Market Revenue, by End User (2017–2030)
Chapter 19. Spain Market
19.1. Overview
19.2. Market Revenue, by Product (2017–2030)
19.3. Market Revenue, by Indication (2017–2030)
19.4. Market Revenue, by End User (2017–2030)
Chapter 20. Japan Market
20.1. Overview
20.2. Market Revenue, by Product (2017–2030)
20.3. Market Revenue, by Indication (2017–2030)
20.4. Market Revenue, by End User (2017–2030)
Chapter 21. China Market
21.1. Overview
21.2. Market Revenue, by Product (2017–2030)
21.3. Market Revenue, by Indication (2017–2030)
21.4. Market Revenue, by End User (2017–2030)
Chapter 22. India Market
22.1. Overview
22.2. Market Revenue, by Product (2017–2030)
22.3. Market Revenue, by Indication (2017–2030)
22.4. Market Revenue, by End User (2017–2030)
Chapter 23. Australia Market
23.1. Overview
23.2. Market Revenue, by Product (2017–2030)
23.3. Market Revenue, by Indication (2017–2030)
23.4. Market Revenue, by End User (2017–2030)
Chapter 24. South Korea Market
24.1. Overview
24.2. Market Revenue, by Product (2017–2030)
24.3. Market Revenue, by Indication (2017–2030)
24.4. Market Revenue, by End User (2017–2030)
Chapter 25. Brazil Market
25.1. Overview
25.2. Market Revenue, by Product (2017–2030)
25.3. Market Revenue, by Indication (2017–2030)
25.4. Market Revenue, by End User (2017–2030)
Chapter 26. Mexico Market
26.1. Overview
26.2. Market Revenue, by Product (2017–2030)
26.3. Market Revenue, by Indication (2017–2030)
26.4. Market Revenue, by End User (2017–2030)
Chapter 27. Saudi Arabia Market
27.1. Overview
27.2. Market Revenue, by Product (2017–2030)
27.3. Market Revenue, by Indication (2017–2030)
27.4. Market Revenue, by End User (2017–2030)
Chapter 28. South Africa Market
28.1. Overview
28.2. Market Revenue, by Product (2017–2030)
28.3. Market Revenue, by Indication (2017–2030)
28.4. Market Revenue, by End User (2017–2030)
Chapter 29. U.A.E. Market
29.1. Overview
29.2. Market Revenue, by Product (2017–2030)
29.3. Market Revenue, by Indication (2017–2030)
29.4. Market Revenue, by End User (2017–2030)
Chapter 30. Competitive Landscape
30.1. List of Market Players and their Offerings
30.2. Competitive Benchmarking of Key Players
30.3. Product Benchmarking of Key Players
30.4. Recent Strategic Developments
Chapter 31. Company Profiles
31.1. Olympus Corporation
31.1.1. Business overview
31.1.2. Product and service offerings
31.1.3. Key financial summary
31.2. Boston Scientific Corporation
31.2.1. Business overview
31.2.2. Product and service offerings
31.2.3. Key financial summary
31.3. FUJIFILM Holdings Corporation
31.3.1. Business overview
31.3.2. Product and service offerings
31.3.3. Key financial summary
31.4. Sumitomo Bakelite Co. Ltd.
31.4.1. Business overview
31.4.2. Product and service offerings
31.4.3. Key financial summary
31.5. Creo Medical Group plc
31.5.1. Business overview
31.5.2. Product and service offerings
31.5.3. Key financial summary
31.6. MTW-Endoskopie W.Haag KG
31.6.1. Business overview
31.6.2. Product and service offerings
31.7. Ovesco Endoscopy AG
31.7.1. Business overview
31.7.2. Product and service offerings
31.8. KARL STORZ SE & Co. KG
31.8.1. Business overview
31.8.2. Product and service offerings
31.9. CONMED Corporation
31.9.1. Business overview
31.9.2. Product and service offerings
31.9.3. Key financial summary
31.10. MICRO-TECH (Nanjing) Co. Ltd.
31.10.1. Business overview
31.10.2. Product and service offerings
31.11. Medtronic plc
31.11.1. Business overview
31.11.2. Product and service offerings
31.11.3. Key financial summary
31.12. HOYA Corporation
31.12.1. Business overview
31.12.2. Product and service offerings
31.12.3. Key financial summary
31.13. STERIS plc
31.13.1. Business overview
31.13.2. Product and service offerings
31.13.3. Key financial summary
31.14. Cook Group Incorporated
31.14.1. Business overview
31.14.2. Product and service offerings
31.15. Leo Medical Co. Ltd.
31.15.1. Business overview
31.15.2. Product and service offerings
Chapter 32. Appendix
32.1. Abbreviations
32.2. Sources and References
32.3. Related Reports
| ※参考情報 内視鏡的粘膜下層剥離術（ESD）は、内視鏡を用いて消化管の粘膜層及びその下の粘膜下層を剥離する技術の一つです。ESDは特に胃や食道、大腸において早期癌や腫瘍の治療に活用されます。この手法は、外科的手術に比べて侵襲性が低く、患者にとっての負担が軽減される点が特徴です。ESDは内視鏡的治療の中でも、非常に進んだ技術の一つとされています。 ESDにはいくつかの種類がありますが、主に用いられる形式は、腫瘍のサイズや部位に応じたアプローチになります。たとえば、小さい腫瘍の場合には、一度に広範囲を剥離することができる「大きな切除技術」が用いられます。一方、大きな腫瘍や複数の病変が存在するときには、逐次的に剥離を行う「分回切除技術」が採用されることがあります。 ESDの主な用途は、早期癌の治療です。内視鏡を使用することで、粘膜下层に埋まった腫瘍を直接的に切除することが可能となり、手術のリスクを軽減することに繋がります。また、腫瘍がまだ浸潤していない場合には、ESDによって完全に切除することができ、必要に応じて後の治療を避けることができます。そうした治療の進展によって、多くの患者が早期に回復することが期待されます。 関連技術としては、内視鏡的高度切除（EMR）や内視鏡的縫合術などが存在します。EMRは、主に腫瘍が小さい場合に適用される手法で、食道や胃、大腸において広く利用されていますが、ESDに比べて再発率が高いことが一般的です。また、最近ではロボット支援内視鏡手術との組み合わせが試みられており、より精密な操作が可能となることが期待されています。これにより、ESDの適用範囲が拡大し、今後もさらなる技術革新が進むと考えられています。 ESDは、従来の内視鏡的手法と比べて、手術の精度と安全性を向上させるためにいくつかの特徴を持っています。たとえば、特別な内視鏡具や切除デバイスなどを用いることで、より確実に腫瘍を取り除くことが可能です。これらの器具は高解像度の画像を提供し、リアルタイムでのモニタリングを行うことができます。加えて、ESDにおいては治療後の出血や穿孔といった合併症のリスクを最小限に抑えるために、術後管理も重要です。 ただし、ESDにもいくつかの課題があります。たとえば、技術的に難易度が高く、熟練した医師でも手技の習得には時間を要するため、施行できる施設が限られることがあります。また、高度な技術を要するため、施術後の合併症や再発のリスクに対して、十分な知識と経験が求められます。今後の技術向上や教育の充実により、ESDの普及が進むことが期待されます。 総じて、内視鏡的粘膜下層剥離術（ESD）は、消化管の早期癌や腫瘍の治療において重要な役割を果たしており、ここ最近の医療技術の進歩により、その可能性はさらに広がっています。これからも新しい技術や方法論が導入されることで、より多くの患者に利便性と安全性を提供できるようになるでしょう。ESDの発展に期待が寄せられる中、医療現場での活用が進むことを願っています。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
